RELATION BETWEEN BODY POSTURE and SHOULDER DYSFUNCTION

August 31, 2024 updated by: Amr Saad Tawfik Soliman, Cairo University

CORRELATION BETWEEN SHOULDER DYSFUNCTION and FRONTAL PLANE POSTURE in SUBACROMIAL IMPINGEMENT SYNDROME

The purpose of this study will be to investigate if there is any correlation between shoulder dysfunction and the lateral alignment of the spine, scapular dyskinesia, pelvic tilting angle, Shoulder height angle, and trunk side bending (strength and mobility) in the frontal plane in patients with unilateral SIS.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

This study will be conducted to answer the following question:

Is there any correlation between shoulder dysfunction and the lateral alignment of the spine, scapular dyskinesia, pelvic tilting angle, Shoulder height angle, and trunk side bending (strength and mobility) in the frontal plane in patients with unilateral SIS?

This study will be limited to:

  1. Thirty four (34) patients with unilateral SIS.
  2. Male and female subjects will be included between 20 and 40 years of age .
  3. Shoulder pain and disability level will be measured using the Arabic version of shoulder pain and disability index (SPADI).
  4. Thoracolumbar lateral deviation will be measured using a scoliometer.
  5. Scapular dyskinesia will be measured using lateral scapular slide test (LSST).
  6. The pelvic tilting angle and shoulder height angle will be evaluated using Kinovea software.
  7. Trunk side bending ROM will be evaluated using a bubble inclinometer .
  8. Trunk side bending strength will be evaluated using a handheld dynamometer.

Assumptions:

It will be assumed that:

  1. The instructions given to all individuals will be clear with satisfying explanations for all assessment methods.
  2. All individuals will follow the instructions.

Hypotheses:

It will be hypothesized that:

  1. There will be no significant correlation between pain score and measured variables in patients with unilateral SIS:

    1. lateral spinal deviation
    2. scapular dyskinesia
    3. pelvic tilting angle in the frontal plane
    4. shoulder height angle in the frontal plane
    5. ipsilateral trunk lateral side bending ROM
    6. contralateral trunk lateral side bending ROM
    7. ipsilateral trunk lateral side bending strength
    8. contralateral trunk lateral side bending strength

  2. There will be no significant correlation between disability score and measured variables in patients with unilateral SIS:

    1. lateral spinal deviation
    2. scapular dyskinesia
    3. pelvic tilting angle in the frontal plane
    4. shoulder height angle in the frontal plane
    5. ipsilateral trunk lateral side bending ROM
    6. contralateral trunk lateral side bending ROM
    7. ipsilateral trunk lateral side bending strength
    8. contralateral trunk lateral side bending strength

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
34

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

  • Name: AMR SAAD TAWFIK SOLIMAN, demonstrator
  • Phone Number: 00201002043808 +201002043808
  • Email: amrsaadtawfik@cu.edu.eg

Study Locations

  • Egypt
      • Cairo, Egypt
        • Recruiting
        • Faculty of Physical Therapy Cairo University
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Thirty four (34) patients with unilateral SIS. Male and female subjects will be included between 20 and 40 years of age with a BMI between 18.5 to 29.9 kg/m2.

Description

Inclusion Criteria:

  1. Non-athletic patients of both sexes.
  2. referred by an orthopedic surgeon with a diagnosis of unilateral SIS (Stage I, or II).
  3. Patients aged between 20 to 40 years.
  4. BMI between 18.5 to 29.9 kg/m2.

  5. having four or more of the following findings:

    • Shoulder pain that is located either anteriorly or laterally to the acromion process
    • Pain worsening by shoulder flexion and/or abduction
    • A painful movement arc ranging from 60° to 120°
    • A palpably painful greater tuberosity of the humerus
    • The pain is replicated using the supraspinatus empty-can test, A positive Neer impingement sign, external rotation resistance test, and a positive Hawkins sign.

Exclusion Criteria:

  1. Systematic illnesses
  2. Pregnancy
  3. Any degenerative disorder or disc lesion affection of the spine
  4. A history of upper limb or spinal surgery
  5. Previous upper limb or spinal fractures
  6. Post-traumatic shoulder pain
  7. History of shoulder instability (positive Sulcus sign, positive apprehension test, and history of shoulder dislocation)
  8. Clinical signs of cervical radiculopathy (pain related to cervical movements)
  9. Adhesive capsulitis
  10. Tumors
  11. Shoulder labral or cartilage lesions
  12. Capsular or ligamentous tears or avulsions
  13. any apparent deformity in the lower limbs including leg length discrepancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Thoracolumbar lateral deviation
Time Frame: 2 MONTHES
will be measured using a scoliometer
2 MONTHES
Scapular dyskinesia
Time Frame: 2 monthes
will be measured using lateral scapular slide test (LSST)
2 monthes
The pelvic tilting angle and shoulder height angle
Time Frame: 2 monthes
will be evaluated using Kinovea software
2 monthes
Trunk side bending ROM
Time Frame: 2 Monthes
will be evaluated using a bubble inclinometer
2 Monthes
Trunk side bending strength
Time Frame: 2 monthes
will be evaluated using a handheld dynamometer
2 monthes
Shoulder pain and disability level
Time Frame: 2 monthes
will be measured using the Arabic version of shoulder pain and disability index (SPADI)
2 monthes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 19, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 30, 2024

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
October 15, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 18, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 23, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 25, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 4, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 31, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • P.T.REC/012/005179

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

I do not have enough information right now

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Subacromial Impingement Syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings